P-106 * Pembrolizumab (MK-3475) versus paclitaxel as...

P-106 * Pembrolizumab (MK-3475) versus paclitaxel as second-line therapy for advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma: Randomized, open-label, phase 3 KEYNOTE-061 study

Ohtsu, A., Tabernero, J., Bang, Y.- J., Fuchs, C., Sun, L., Wang, Z., Csiki, I., Koshiji, M., Van Cutsem, E.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.106
Date:
June, 2015
File:
PDF, 37 KB
english, 2015
Conversion to is in progress
Conversion to is failed